Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs ...

Biotechnology company Leucid Bio announced a strategic collaboration with Syenex, an open-source gene therapy platform firm.

A new clinical trial has shown promising safety and efficacy results for liraglutide in the treatment of Alzheimer’s disease.

Authors explore complexities in scaling gene-therapy production with special attention is to monitoring and enhancing ...

We speak with a member of BioProcess International's editorial advisory board about the link between friendship and business.

The company is struggling to make ends meet as it loses a major undisclosed client.

But before we say goodbye to 2025, we leave you with five of our favorite features from this year, delving deeper into a few ...

Non-profit life sciences incubator Massachusetts Biomedical Initiatives (MBI) announced that three new companies joined its ...

BPI contributor Justin Byers is cofounder and chief executive officer of Axio BioPharma.

Figure 1A: Antibody–drug conjugate (ADC) structure and delivery pathways; linker chemistry determines the mechanism by which cytotoxin release occurs. This schematic shows a monoclonal antibody (MAb) ...

Ion-exchange chromatography (IEC) is a common method for oligonucleotide purification (1, 2). Separation by IEC often uses strong–anion-exchange (AEX) resins at moderate to strongly basic pH values. A ...

The biopharmaceutical industry is at the forefront of technological advancements, with “biopharma 4.0” revolutionizing the way biomanufacturing is conducted (1). The concept combines automation, ...